Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 888 | 1,042 | 970 | 874 | 1,770 |
| Income taxes - deferred | -505 | -464 | 0 | -1,087 | -354 |
| Accounts receivable | -1,746 | -3,939 | 415 | -2,469 | 310 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 146 | N/A |
| Other Working Capital | 640 | -3,030 | 501 | -389 | 1,803 |
| Other Operating Activity | 4,421 | 8,204 | 2,567 | 6,359 | 1,865 |
| Operating Cash Flow | $3,698 | $1,813 | $4,453 | $3,433 | $5,394 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -1 | -22 | -15 | -26 |
| Sale Of Investment | 0 | 0 | 0 | -4 | 3 |
| Other Investing Activity | 88 | 94 | 73 | 73 | 48 |
| Investing Cash Flow | $68 | $94 | $52 | $54 | $26 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | 0 | N/A | N/A | 5 | -781 |
| Dividend Paid | -945 | -1,128 | -1,052 | -2,806 | -1,198 |
| Other Financing Activity | 0 | 0 | 0 | -9 | 0 |
| Financing Cash Flow | $-945 | $-1,128 | $-1,052 | $-2,811 | $-1,979 |
| Exchange Rate Effect | 1 | -5 | 33 | 20 | -12 |
| Beginning Cash Position | 37,909 | 35,964 | 32,479 | 33,776 | 29,874 |
| End Cash Position | 39,246 | 37,909 | 35,964 | 33,718 | 33,776 |
| Net Cash Flow | $2,822 | $779 | $3,452 | $676 | $3,441 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,698 | 1,813 | 4,453 | 3,433 | 5,394 |
| Capital Expenditure | -20 | -1 | -22 | -13 | -68 |
| Free Cash Flow | 3,679 | 1,812 | 4,431 | 3,420 | 5,326 |